会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Oligonucleotide therapies for modulating the effects of herpesviruses
    • 用于调节疱疹病毒的作用的寡核苷酸疗法
    • US5658891A
    • 1997-08-19
    • US329212
    • 1994-10-26
    • Kenneth G. DraperDavid J. EckerChristopher K. MirabelliStanley T. Crooke
    • Kenneth G. DraperDavid J. EckerChristopher K. MirabelliStanley T. Crooke
    • A61K31/70A61K38/00A61K48/00A61P31/12A61P31/22C07H21/00C07K14/03C12N7/04C12N15/09C12N15/113C12Q1/68C12N5/10
    • C12N15/1133C07K14/005A61K38/00C12N2310/3125C12N2310/315C12N2710/16622
    • Compositions and methods are provided for the treatment and diagnosis of herpesvirus infections. In accordance with preferred embodiments, oligonucleotides are provided which are specifically hybridizable with RNA or DNA deriving from a gene corresponding to one of the open reading frames UL5, UL8, UL9, UL13, UL29, UL30, UL39, UL40, UL42 AND UL52 of herpes simplex virus type 1. The oligonucleotide comprises nucleotide units sufficient in identity and number to effect said specific hybridization. In other preferred embodiments, the oligonucleotides are specifically hybridizable with a translation initiation site; it is also preferred that they comprise the sequence CAT. Methods of treating animals suspected of being infected with herpesvirus comprising contacting the animal with an oligonucleotide specifically hybridizable with RNA or DNA deriving from one of the foregoing genes of the herpesvirus; are disclosed. Methods for treatment of infections caused by herpes simplex virus type 1, herpes simplex virus type 2, cytomegalovirus, human herpes virus 6, Epstein Barr virus or varicella zoster virus are disclosed.
    • 提供组合物和方法用于治疗和诊断疱疹病毒感染。 根据优选实施方案,提供寡核苷酸,其与衍生自相应于疱疹的开放阅读框UL5,UL8,UL9,UL13,UL29,UL30,UL39,UL29,UL30,UL39,UL40,UL42和UL52中的一个的基因的RNA或DNA特异性杂交 单克隆病毒类型1.寡核苷酸包含足以实现所述特异性杂交的同一性和数目的核苷酸单元。 在其它优选实施方案中,寡核苷酸与翻译起始位点特异性杂交; 还优选它们包含序列CAT。 治疗疑似感染疱疹病毒的动物的方法,包括使动物与可衍生自疱疹病毒的前述基因之一的RNA或DNA特异性杂交的寡核苷酸接触; 被披露。 公开了用于治疗由单纯疱疹病毒1型,2型单纯疱疹病毒,巨细胞病毒,人疱疹病毒6,爱泼斯坦巴尔病毒或水痘带状疱疹病毒引起的感染的方法。
    • 4. 发明授权
    • Oligonucleotide therapies for modulating the effects of herpesviruses
    • 用于调节疱疹病毒的作用的寡核苷酸疗法
    • US06310044B1
    • 2001-10-30
    • US07852132
    • 1992-04-28
    • Kenneth G. DraperDavid J. EckerChristopher K. MirabelliStanley T. Crooke
    • Kenneth G. DraperDavid J. EckerChristopher K. MirabelliStanley T. Crooke
    • A61K4800
    • C12N15/1133A61K38/00C07K14/005C12N2310/3125C12N2310/315C12N2710/16622
    • Compositions and methods are provided for the treatment and diagnosis of herpesvirus infections. In accordance with preferred embodiments, oligonucleotides are provided which are specifically hybridizable with RNA or DNA deriving from a gene corresponding to one of the open reading frames UL5, UL8, UL9, UL13, UL29, UL30, UL39, UL40, UL42 AND UL52 of herpes simplex virus type 1. The oligonucleotide comprises nucleotide units sufficient in identity and number to effect said specific hybridization. In other preferred embodiments, the oligonucleotides are specifically hybridizable with a translation initiation site; it is also preferred that they comprise the sequence CAT. Methods of treating animals suspected of being infected with herpesvirus comprising contacting the animal with an oligonucleotide specifically hybridizable with RNA or DNA deriving from one of the foregoing genes of the herpesvirus are disclosed. Methods for treatment of infections caused by herpes simplex virus type 1, herpes simplex virus type 2, cytomegalovirus, human herpes virus 6, Epstein Barr virus or varicella zoster virus are disclosed.
    • 提供组合物和方法用于治疗和诊断疱疹病毒感染。 根据优选实施方案,提供寡核苷酸,其与衍生自相应于疱疹的开放阅读框UL5,UL8,UL9,UL13,UL29,UL30,UL39,UL29,UL30,UL39,UL40,UL42和UL52中的一个的基因的RNA或DNA特异性杂交 单克隆病毒类型1.寡核苷酸包含足以实现所述特异性杂交的同一性和数目的核苷酸单元。 在其它优选实施方案中,寡核苷酸与翻译起始位点特异性杂交; 还优选它们包含序列CAT。 公开了治疗疑似被疱疹病毒感染的动物的方法,包括使动物与可衍生自疱疹病毒的前述基因之一的RNA或DNA特异性杂交的寡核苷酸接触。 公开了用于治疗由单纯疱疹病毒1型,2型单纯疱疹病毒,巨细胞病毒,人疱疹病毒6,爱泼斯坦巴尔病毒或水痘带状疱疹病毒引起的感染的方法。
    • 6. 发明授权
    • Oligonucleotides for Papillomavirus
    • 乳头瘤病毒的寡核苷酸
    • US5811232A
    • 1998-09-22
    • US692257
    • 1996-08-05
    • Stanley T. CrookeChristopher K. MirabelliDavid J. EckerLex M. Cowsert
    • Stanley T. CrookeChristopher K. MirabelliDavid J. EckerLex M. Cowsert
    • C12Q1/68C12Q1/70C07H21/04
    • C12Q1/70C12Q1/6883Y10S435/81
    • Oligonucleotides and oligonucleotide analogs are provided which are capable of antisense interaction with messenger RNA of papillomavirus. Such oligonucleotides or oligonucleotide analogs can be used for diagnostics and therapeutics as well as for research purposes. In accordance with preferred embodiments of this invention, oligonucleotide or oligonucleotide analog is provided which is hybridizable with a messenger RNA from a papillomavirus. The oligonucleotide or oligonucleotide analog is able to inhibit the function of the RNA, and accordingly is useful for therapy for infections by such papillomavirus. In accordance with a preferred embodiment, portions of the papillomavirus are targeted for antisense attack. Thus oligonucleotides are preferably provided which hybridize with the E2, E1, E7, or E6-7 messenger RNAs.
    • 提供寡核苷酸和寡核苷酸类似物,其能够与乳头瘤病毒的信使RNA反义相互作用。 这样的寡核苷酸或寡核苷酸类似物可用于诊断和治疗以及用于研究目的。 根据本发明的优选实施方案,提供可与来自乳头瘤病毒的信使RNA杂交的寡核苷酸或寡核苷酸类似物。 寡核苷酸或寡核苷酸类似物能够抑制RNA的功能,因此可用于由这种乳头瘤病毒感染的治疗。 根据优选实施方案,乳头瘤病毒的一部分被靶向用于反义攻击。 因此优选提供与E2,E1,E7或E6-7信使RNA杂交的寡核苷酸。
    • 8. 发明授权
    • Antisense oligonucleotide inhibition of papillomavirus
    • 反义寡核苷酸抑制乳头瘤病毒
    • US06174870B1
    • 2001-01-16
    • US09130426
    • 1998-08-06
    • Stanley T. CrookeChristopher K. MirabelliDavid J. EckerLex M. Cowsert
    • Stanley T. CrookeChristopher K. MirabelliDavid J. EckerLex M. Cowsert
    • A61K3170
    • C12Q1/708C12Q1/6883C12Q2525/101
    • Oligonucleotides and oligonucleotide analogs are provided which are capable of antisense interaction with messenger RNA of papillomavirus. Such oligonucleotides or oligonucleotide analogs can be used for diagnostics and therapeutics as well as for research purposes. In accordance with preferred embodiments of this invention, oligonucleotide or oligonucleotide analog is provided which is hybridizable with a messenger RNA from a papillomavirus. The oligonucleotide or oligonucleotide analog is able to inhibit the function of the RNA, and accordingly is useful for therapy for infections by such papillomavirus. In accordance with a preferred embodiment, portions of the papillomavirus are targeted for antisense attack. Thus oligonucleotides are preferably provided which hybridize with the E2, E1, E7, E6 or E6-7 messenger RNAs.
    • 提供寡核苷酸和寡核苷酸类似物,其能够与乳头瘤病毒的信使RNA反义相互作用。 这样的寡核苷酸或寡核苷酸类似物可用于诊断和治疗以及用于研究目的。 根据本发明的优选实施方案,提供可与来自乳头瘤病毒的信使RNA杂交的寡核苷酸或寡核苷酸类似物。 寡核苷酸或寡核苷酸类似物能够抑制RNA的功能,因此可用于由这种乳头瘤病毒感染的治疗。根据优选实施方案,部分乳头瘤病毒是针对反义发作的。 因此优选提供与E2,E1,E7,E6或E6-7信使RNA杂交的寡核苷酸。